Treatment  	Treatment  	 NN	O
of  	of  	 IN	O
haemophilia  	haemophilia  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
elderly  	elderly  	 JJ	O
Treatment  	Treatment  	 NNP	O
of  	of  	 IN	O
elderly  	elderly  	 JJ	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
haemophilia  	haemophilia  	 NN	O
is  	is  	 VBZ	O
an  	an  	 DT	O
upcoming  	upcoming  	 JJ	O
challenge  	challenge  	 NN	O
in  	in  	 IN	O
haemophilia  	haemophilia  	 JJ	B-NP
care 	care 	 NN	I-NP
.  	.  	 .	O
We  	We  	 PRP	O
included  	included  	 VBD	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
haemophilia  	haemophilia  	 VBG	O
A  	A  	 DT	O
older  	older  	 JJR	O
than  	than  	 IN	O
60  	60  	 CD	O
years  	years  	 NNS	O
of  	of  	 IN	O
age 	age 	 NN	O
,  	,  	 ,	O
who  	who  	 WP	O
visited  	visited  	 VBD	O
our  	our  	 PRP$	O
haemophilia  	haemophilia  	 JJ	O
centre  	centre  	 NN	O
between  	between  	 IN	O
2006  	2006  	 CD	O
and  	and  	 CC	O
2008 	2008 	 CD	O
.  	.  	 .	O
We  	We  	 PRP	O
conducted  	conducted  	 VBD	O
a  	a  	 DT	O
retrospective  	retrospective  	 JJ	B-NP
study  	study  	 NN	I-NP
focussing  	focussing  	 NN	I-NP
on  	on  	 IN	O
the  	the  	 DT	O
patients 	patients 	 NNS	O
'  	'  	 POS	O
co-morbidities  	co-morbidities  	 JJ	B-NP
as  	as  	 IN	O
well  	well  	 RB	O
as  	as  	 IN	O
changes  	changes  	 NNS	O
in  	in  	 IN	O
their  	their  	 PRP$	O
bleeding  	bleeding  	 JJ	O
patterns  	patterns  	 NNS	O
between  	between  	 IN	O
2003  	2003  	 CD	O
and  	and  	 CC	O
2008 	2008 	 CD	O
.  	.  	 .	O
There  	There  	 EX	O
is  	is  	 VBZ	O
a  	a  	 DT	O
tendency  	tendency  	 NN	O
of  	of  	 IN	O
increasing  	increasing  	 VBG	O
bleeding  	bleeding  	 JJ	O
symptoms  	symptoms  	 NNS	B-NP
with  	with  	 IN	O
increasing  	increasing  	 VBG	B-NP
age  	age  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
patients  	patients  	 NNS	O
due  	due  	 JJ	O
to  	to  	 TO	O
more  	more  	 RBR	O
frequent  	frequent  	 JJ	O
spontaneous  	spontaneous  	 JJ	B-NP
joint  	joint  	 JJ	I-NP
bleedings 	bleedings 	 NN	I-NP
,  	,  	 ,	O
malignancies  	malignancies  	 NN	O
or  	or  	 CC	O
treatment  	treatment  	 NN	O
with  	with  	 IN	O
phenprocoumon  	phenprocoumon  	 NN	B-NP
or  	or  	 CC	O
ASS 	ASS 	 NNP	O
.  	.  	 .	O
In  	In  	 IN	O
consequence 	consequence 	 NN	O
,  	,  	 ,	O
FVIII  	FVIII  	 NNP	B-NP
dosage  	dosage  	 NN	I-NP
had  	had  	 VBD	O
to  	to  	 TO	O
be  	be  	 VB	O
increased  	increased  	 VBN	O
for  	for  	 IN	O
8  	8  	 CD	O
patients  	patients  	 NNS	O
( 	( 	 -LRB-	O
28 	28 	 CD	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Chronic  	Chronic  	 NNP	B-NP
hepatitis  	hepatitis  	 NNP	I-NP
C 	C 	 NNP	I-NP
,  	,  	 ,	O
coronary  	coronary  	 JJ	B-NP
heart  	heart  	 NN	I-NP
disease  	disease  	 NN	I-NP
and  	and  	 CC	O
malignancies  	malignancies  	 NNS	O
are  	are  	 VBP	O
the  	the  	 DT	O
most  	most  	 RBS	O
frequent  	frequent  	 JJ	O
co-morbidities 	co-morbidities 	 NN	B-NP
.  	.  	 .	O
